NCT05165160View on ClinicalTrials.gov

Residual Disease Evaluation of Resected NSCLC by cirDNA Analysis

NAActive, not recruitingINTERVENTIONAL

Enrollment

133

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

July 15, 2025

Study Completion Date

July 15, 2025

Conditions

Nsclc

Interventions

DIAGNOSTIC_TEST

Blood sample

Pre- and postoperative blood sample

Trial Locations (1)

34295

University Hospital, Montpellier

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER